Sialidase: Key Enzyme in Tissue Metabolism and Immune System (P11282)

Target Name: Sialidase

NCBI ID: P11282

Sialidase

Other Name(s): Sialidase

Sialidase: Key Enzyme in Tissue Metabolism and Immune System

Sialidase (also known as nonspecified subtype) is a protein that is found in various cell types throughout the body. It is a key enzyme that is involved in the metabolism of sialic acids, which are a type of carbohydrate found on the surface of many different cell types. Sialidase is often used as a drug target or biomarker, and there is ongoing research into its potential uses in treating a variety of diseases.

One of the main functions of sialidase is to break down sialic acids, which are attached to the surface of many different cell types. This process is important for the proper functioning of those cells, and it is also involved in the development and maintenance of tissues such as the skin, bone, and nervous system. Sialidase is able to break down sialic acids, which allows cells to remove the carbohydrates from their surface and prepare for other types of cell growth and development.

Sialidase is also involved in the regulation of the immune system. It is a key player in the immune response, and it is able to help the body fight off infections and diseases. Sialidase is able to interact with other immune system proteins, which allows it to play a critical role in protecting the body against infection and disease.

In addition to its role in the immune system, sialidase is also involved in the regulation of the growth and development of cells. It is able to promote the growth and development of certain types of cells, and it is also involved in the regulation of cell division. This helps to ensure that cells are able to grow and divide properly, which is essential for the development and maintenance of tissues.

Sialidase is also a potential drug target or biomarker because of its role in the development and maintenance of tissues. Many diseases are caused by problems with the development and maintenance of tissues, and sialidase may be a useful target for treating those diseases. For example, some studies are investigating the potential uses of sialidase in treating skin diseases, such as acne and psoriasis. Other studies are looking at the potential uses of sialidase in treating bone diseases, such as osteoporosis.

In addition to its potential uses in treating diseases, sialidase is also being studied as a biomarker for monitoring the effectiveness of certain treatments. By measuring the levels of sialidase in the body, researchers can get a sense of how well certain treatments are working and whether they are having the desired impact on the body. This information can be valuable for doctors to use in the development of new treatments and for researchers to use in their studies of the immune system and the regulation of tissues.

Overall, sialidase is a protein that plays a critical role in the development and maintenance of tissues throughout the body. It is involved in the metabolism of sialic acids, which are attached to the surface of many different cell types, and it is also involved in the regulation of the immune system and the growth and development of cells. As a result, sialidase is an attractive target for researchers to study and to use in the development of new treatments for a variety of diseases.

Protein Name: Sialidase (nonspecified Subtype)

The "Sialidase Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Sialidase comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets